Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Diseaseswe target
    • Diseases we target
    • Leber Hereditary Optic Neuropathy (LHON)
    • Retinitis Pigmentosa (RP)
    • Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
    • Clinical development Summary
  • Investors
    • Company Overview
    • Financial press releases
    • Investor Newsletters
    • Events & presentations
    • Stock information & Financial agenda
    • Governance
    • Documentation
  • Media

GS010 - LUMEVOQ

28 Oct 2021 - 29 Oct 2021

Cell UK by Oxford’s Global, London (UK) & Virtual

25 Oct 2021 - 28 Oct 2021

BIO-Europe 2021, Virtual

15 Oct 2021 - 16 Oct 2021

Mitochondrial Diseases Conference 2021 by Mitocon, Virtual

19 Oct 2021 - 22 Oct 2021

28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT), Virtual

12 Oct 2021 - 14 Oct 2021

2021 ARM Cell & Gene Meeting on the Mesa, Carlsbad, CA (USA) & Virtual

06 October 2021

GenSight Biologics Announces the Publication of a Review of Gene Therapy Trials for LHON in International Ophthalmology Clinics

07 Oct 2021

OIS Retina Innovation Summit @ASRS, Austin, TX (USA)

05 Oct 2021 - 06 Oct 2021

2021 Advanced Therapies Congress LIVE, London (UK)

04 October 2021

Clinical Data on GenSight Biologics’ LUMEVOQ® and GS030 Gene Therapies to be Presented at 2021 ASRS, ESGCT and Several Investor and Industry Meetings in October

28 Sep 2021 - 29 Sep 2021

Advanced Therapies Connect, online event

  • View previous 9 articles
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 17
  • View next 9 articles
© 2025 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
  • Cookies management
Go back to the page of the page